Hepatic osteodystrophy: The influence of liver disease and portal hypertension on cytokine activation

Medical Hypotheses

Volumn 54, Issue 5, 2000, Pages 842-845

  Merwe, S W Van Der ^a   Attfield, D ^a   Fevery, J ^a   Bogaerde, J B Van Den ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

BONE ATROPHY; CHRONIC LIVER DISEASE; HUMAN; OSTEOBLAST; OSTEOCLAST; OSTEODYSTROPHY; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; REVIEW;

EID: 0034030167     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1999.0963     Document Type: Article

References (27)

1. Van den Bogaerde J. B., Beynon H. L. C. Musculoskeletal problems in liver disease. McIntyre B. Oxford Textbook of Hepatology, 2nd ed. 1998;OUP, Oxford.
2. Dempster D. W., Lindsay R. Pathogenesis of osteoporosis. Lancet. 341:1993;797-801.
3. Diamond T., Stiel D., Lunzer M., Wilkonson M., Roche J., Posen S. Osteoporosis and skeletal fracture in chronic liver disease. Gut. 31:1990;82-87.
4. Chen C., Wang S., Jeng F., Lee S. Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis? J Gasteroenterol Hepatol. 11:1996;417-421.
5. Idilman R., de Maria N., Uzunalimoglu O., van Thiel D. H. Hepatic osteodystrophy: a review. Hepatogastroenterology. 44:1997;574-581.
6. Dibble J. B., Sheridan P., Hampshire R., Hardy G. J., Losowsky M. S. Osteomalacia, vitamin D deficiency and cholestasis in chronic liver disease. Q J Med. 201:1982;89-103.
7. Janes C., Dickson E., Bonde S., McDonagh A., Riggs B. Role of hyperbilirubinemia in inhibition of osteoblast proliferation in patients with chronic cholestatic jaundice. J Bone Miner Res. 7:1992;S98.
8. Diamond T. H., Stiel D., Lunzert M., McDowall D., Eckstein R. P., Posen S. Hepatic osteodystrophy: static and dynamic bone histomorphometry and serum bone gla-protein in 80 patients with chronic liver disease. Gastroenterology. 96:1989;213-221.
9. Bonkovsky B. L., Hawkins M., Steinberg K. Prevelance and prediction of osteopenia in chronic liver disease. Hepatology. 12:1990;273-280.
10. Tsuneoka K., Tameda Y., Takase K., Nakano T. Osteodystrophy in patients with chronic hepatitis and liver cirrhosis. J Gastroenterol. 31:1996;669-678.
11. Crippin J. S., Jorgensen R. A., Dickson E. R., Lindor K. D. Hepatic osteodystrophy in primary biliary cirrhosis; effects of medical treatment. Am J Gastroenterol. 89:1994;47-50.
12. Mason J. B., Rosenberg I. H. Hepatobiliary influences on the skeletal system. Arias I. M., Boyer J. L., Fausto N., Jakoby W. B., Schachter D. The liver biology and pathobiology. 1984;1257-1266 Raven Press, New York.
13. Bolt M. J. G., Sitrin M., Faws M., Rosenberg I. H. Hepatic vitamin D 25-hydroxylase: inhibition by bile duct ligation or bile salt. Hepatology. 5:1981;436-440.
14. Nakamo A., Kanda T., Abe H. Bone changes and mineral metabolism disorders in rats with experimental liver cirrhosis. J Gastroenterol Hepatol. 11:1996;1143-1154.
15. Floreani A., Zappala F., Fries W. A 3-year pilot study with 1,25-dihydroxyvitamin D, calcium, and calcitonin for severe osteodystrophy in primary biliary cirrhosis. J Clin Gastroenterol. 24:1997;239-244.
16. Slemenda C., Hui S. L., Longcope C., Johnson C. C. Sex steroids and bone mass. A study of changes about the time of menopause. J Clin Invest. 80:1987;1261-1269.
17. Pacifici R., Rifas L., Teitelbaum S. Spontaneous release of interleukin-1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci USA. 84:1987;4616-4620.
18. Pacifici R., Brown C., Puscheck E. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA. 88:1991;5134-5138.
19. Abrahamsen B., Bendtzen K., Beck-Nielsen H. Cytokines and T-lymphocyte subsets in healthy post-menopausal women: estrogen retards bone loss without affecting the release of IL-1 or IL-1ra. Bone. 20:1997;251-258.
20. De Vernejoul M. C. Dynamics of bone remodelling: biochemical and pathophysiological basis. Eur J Clin Chem. 34:1996;729-734.
21. Kimble R. B. Alcohol, cytokines, and oestrogen in the control of bone remodeling. Alcohol Clin Exp Res. 21:1997;385-391.
22. Gowen M., Mundy G. R. Actions of interleukin-1, interleukin-2 and interferon γ on bone resorption in vitro. J Immunol. 136:1986;2478-2482.
23. Nguyen L., Dewhirst F. E., Hauschka P. V., Stashenko P. Interleukin-1β stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytokine Res. 10:1991;15-21.
24. Girasole G., Passeri G., Jilka R. L., Manolagas S. C. Interleukin-11: A new cytokine critical for osteoclast development. J Clin Invest. 93:1994;1516-1524.
25. Kimble R. B., Matayoshi A. B., Vannice J. L., Kung V. T., Williams C., Pacifici R. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology. 136:1995;3054-3061.
26. Ralston S. H., Russell R. G. G., Gowen M. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in post-menopausal women. J Bone Miner Res. 5:1990;983-988.
27. Khoruts A., Stahnke L., McClain C. J., Logan G., Allen J. I. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology. 13:1991;267-276.